38396794|t|The Role of Rosavin in the Pathophysiology of Bone Metabolism.
38396794|a|Rosavin, a phenylpropanoid in Rhodiola rosea's rhizome, and an adaptogen, is known for enhancing the body's response to environmental stress. It significantly affects cellular metabolism in health and many diseases, particularly influencing bone tissue metabolism. In vitro, rosavin inhibits osteoclastogenesis, disrupts F-actin ring formation, and reduces the expression of osteoclastogenesis-related genes such as cathepsin K, calcitonin receptor (CTR), tumor necrosis factor receptor-associated factor 6 (TRAF6), tartrate-resistant acid phosphatase (TRAP), and matrix metallopeptidase 9 (MMP-9). It also impedes the nuclear factor of activated T-cell cytoplasmic 1 (NFATc1), c-Fos, the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB), and mitogen-activated protein kinase (MAPK) signaling pathways and blocks phosphorylation processes crucial for bone resorption. Moreover, rosavin promotes osteogenesis and osteoblast differentiation and increases mouse runt-related transcription factor 2 (Runx2) and osteocalcin (OCN) expression. In vivo studies show its effectiveness in enhancing bone mineral density (BMD) in postmenopausal osteoporosis (PMOP) mice, restraining osteoclast maturation, and increasing the active osteoblast percentage in bone tissue. It modulates mRNA expressions by increasing eukaryotic translation elongation factor 2 (EEF2) and decreasing histone deacetylase 1 (HDAC1), thereby activating osteoprotective epigenetic mechanisms, and alters many serum markers, including decreasing cross-linked C-telopeptide of type I collagen (CTX-1), tartrate-resistant acid phosphatase 5b (TRACP5b), receptor activator for nuclear factor kappa B ligand (RANKL), macrophage-colony-stimulating factor (M-CSF), and TRAP, while increasing alkaline phosphatase (ALP) and OCN. Additionally, when combined with zinc and probiotics, it reduces pro-osteoporotic matrix metallopeptidase 3 (MMP-3), interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-alpha), and enhances anti-osteoporotic interleukin 10 (IL-10) and tissue inhibitor of metalloproteinase 3 (TIMP3) expressions. This paper aims to systematically review rosavin's impact on bone tissue metabolism, exploring its potential in osteoporosis prevention and treatment, and suggesting future research directions.
38396794	12	19	Rosavin	Chemical	MESH:C529148
38396794	63	70	Rosavin	Chemical	MESH:C529148
38396794	74	89	phenylpropanoid	Chemical	-
38396794	93	107	Rhodiola rosea	Species	203015
38396794	338	345	rosavin	Chemical	MESH:C529148
38396794	479	490	cathepsin K	Gene	13038
38396794	492	511	calcitonin receptor	Gene	12311
38396794	513	516	CTR	Gene	12311
38396794	519	569	tumor necrosis factor receptor-associated factor 6	Gene	22034
38396794	571	576	TRAF6	Gene	22034
38396794	579	614	tartrate-resistant acid phosphatase	Gene	11433
38396794	616	620	TRAP	Gene	11433
38396794	627	652	matrix metallopeptidase 9	Gene	17395
38396794	654	659	MMP-9	Gene	17395
38396794	682	730	nuclear factor of activated T-cell cytoplasmic 1	Gene	18018
38396794	732	738	NFATc1	Gene	18018
38396794	741	746	c-Fos	Gene	14281
38396794	752	814	nuclear factor kappa-light-chain-enhancer of activated B cells	Gene	18033
38396794	816	825	NF-kappaB	Gene	18033
38396794	967	974	rosavin	Chemical	MESH:C529148
38396794	1042	1047	mouse	Species	10090
38396794	1048	1083	runt-related transcription factor 2	Gene	12393
38396794	1085	1090	Runx2	Gene	12393
38396794	1096	1107	osteocalcin	Gene	12097
38396794	1109	1112	OCN	Gene	12097
38396794	1208	1235	postmenopausal osteoporosis	Disease	MESH:D010024
38396794	1237	1241	PMOP	Disease	MESH:D010024
38396794	1243	1247	mice	Species	10090
38396794	1392	1434	eukaryotic translation elongation factor 2	Gene	13629
38396794	1436	1440	EEF2	Gene	13629
38396794	1457	1478	histone deacetylase 1	Gene	433759
38396794	1480	1485	HDAC1	Gene	433759
38396794	1703	1755	receptor activator for nuclear factor kappa B ligand	Gene	21943
38396794	1757	1762	RANKL	Gene	21943
38396794	1765	1801	macrophage-colony-stimulating factor	Gene	12977
38396794	1803	1808	M-CSF	Gene	12977
38396794	1815	1819	TRAP	Gene	11433
38396794	1869	1872	OCN	Gene	12097
38396794	1943	1955	osteoporotic	Disease	MESH:D058866
38396794	1956	1981	matrix metallopeptidase 3	Gene	17392
38396794	1983	1988	MMP-3	Gene	17392
38396794	1991	2004	interleukin 6	Gene	16193
38396794	2006	2010	IL-6	Gene	16193
38396794	2017	2044	tumor necrosis factor alpha	Gene	21926
38396794	2046	2055	TNF-alpha	Gene	21926
38396794	2076	2088	osteoporotic	Disease	MESH:D058866
38396794	2089	2103	interleukin 10	Gene	16153
38396794	2105	2110	IL-10	Gene	16153
38396794	2116	2155	tissue inhibitor of metalloproteinase 3	Gene	21859
38396794	2157	2162	TIMP3	Gene	21859
38396794	2218	2225	rosavin	Chemical	MESH:C529148
38396794	2289	2301	osteoporosis	Disease	MESH:D010024
38396794	Negative_Correlation	MESH:C529148	18033
38396794	Positive_Correlation	MESH:C529148	12097
38396794	Association	MESH:D058866	16153
38396794	Negative_Correlation	MESH:C529148	14281
38396794	Negative_Correlation	MESH:C529148	12311
38396794	Negative_Correlation	MESH:C529148	12977
38396794	Association	MESH:D010024	13629
38396794	Association	MESH:C529148	13629
38396794	Association	MESH:D058866	21859
38396794	Negative_Correlation	MESH:C529148	21943
38396794	Negative_Correlation	MESH:C529148	18018
38396794	Positive_Correlation	MESH:C529148	12393
38396794	Negative_Correlation	MESH:C529148	22034
38396794	Association	MESH:D058866	17392
38396794	Negative_Correlation	MESH:C529148	11433
38396794	Negative_Correlation	MESH:C529148	17395
38396794	Negative_Correlation	MESH:C529148	MESH:D010024
38396794	Negative_Correlation	MESH:C529148	433759
38396794	Negative_Correlation	MESH:C529148	13038

